Description of the Company’s Business

Portage Biotech (NASDAQ: PRTG) is a clinical-stage immuno-oncology company advancing first-in-class therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients with cancer. We aim to revolutionize cancer research and development and have created a model dedicated to the advancement of diverse drug platforms, bolstered by proven practices from drug discovery veterans and a strong industry network. The result is a viable product development strategy that supports commercial potential and company growth.

Portage actively engages in the drug development process and provides strategic counsel to guide novel immunotherapy assets and asset combinations from bench through human proof of concept. Our team of scientists, clinicians and pharma-experienced executives have a long history of success, collectively contributing to five oncology drug approvals and creating high-value exits. We reduce the risks associated with early clinical development through more efficient capital management and scientific oversight, and our fail-fast approach enables us to continuously review hundreds of assets and asset combinations, selecting only the most promising to advance. Currently, our portfolio consists of five diverse drug platforms, with 10 products currently in preclinical or clinical development.

Board of Directors

Chairman & Director

Gregory Bailey is a co-founder and Chief Executive Officer of Juvanescence …

Dr. Declan Doogan has over 30 years of industry experience in both major …

Director

Steven Mintz has been a self-employed financial consultant since January …

Non-Executive Director

Kamlesh Shah has more than 25 years of financial and management …

Chief Executive Officer & Director

Dr. Ian Walters has over 20 years of leadership and expertise in …

Country of Incorporation and Registered Office:

The Company is domiciled on the British Virgin Islands and has a registered office and billing address at FH Corporate Services Ltd., of FH Chambers, P.O. Box 4649, Road Town, Tortola, British Virgin Islands

 

Corporate Office

All correspondence and mail should be sent to:

c/o Portage Services Ltd
47 Avenue Rd., Suite 200
Toronto, ON M5R 2G3 Canada
Tel: 416-929-1806
Fax: 416-929-6612

Investor Relations Policy

Insider Trading Policy